Current status of transurethral prostatectomy: A korean multicenter study

Korean Journal of Urology

Volumn 52, Issue 6, 2011, Pages 406-409

  Jang, Dong Gyu ^a   Yoo, Changhee ^a   Oh, Cheol Young ^a   Kim, Se Joong ^b   Kim, Sun Il ^b   Kim, Chun Il ^c   Kim, Hong Sup ^d   Park, Jong Yeon ^e   Seong, Do Hwan ^f   Song, Yun Seob ^g   Yang, Won Jae ^g   Cho, In Rae ^h   Cho, Sung Yong ^h   Cheon, Sang Hyeon ^e   Im, Hyoungjune ^a   Cho, Jin Seon ^a  

^a Hallym University   (South Korea)

^b Ajou University   (South Korea)

^c Keimyung University   (South Korea)

^d Konkuk University   (South Korea)

^e University of Ulsan   (South Korea)

^f Inha University   (South Korea)

^g Soonchunhyang University   (South Korea)

^h Inje University   (South Korea)

Author keywords

Prostatic hyperplasia; References; Transurethral resection of prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER STONE; CONTROLLED STUDY; HEMATURIA; HUMAN; HYDRONEPHROSIS; INTERNATIONAL PROSTATE SYMPTOM SCORE; KOREA; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; ORGAN SIZE; PROSTATE HYPERTROPHY; PROSTATE VOLUME; RECURRENT DISEASE; TRANSURETHRAL RESECTION; TREATMENT INDICATION; URINARY TRACT INFECTION; URINE RETENTION;

EID: 79959813899     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2011.52.6.406     Document Type: Article

References (18)

1. Fitzpatrick JM. Minimally invasive and endoscopic management of benign prostatic hyperplasia. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Phliladelphia: Saunders; 2007;2803-44.
2. AUA Practice Guideline Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170:530-47.
3. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complication. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-7.
4. Son H, Song SH, Paick JS. Current laser treatments for benign prostatic hyperplasia. Korean J Urol 2010;51:737-44.
5. O'Leary MP. Treatment and pharmacologic management of BPH in the context of common comorbidities. Am J Manag Care 2006; 12(5 Suppl):S129-40.
6. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999;83:227-37.
7. Blomqvist P, Ekbom A, Carlsson P, Ahlstrand C, Johansson JE. Benign prostatic hyperplasia in Sweden 1987 to 1994: changing patterns of treatment, changing patterns of costs. Urology 1997; 50:214-9.
8. McConnell JD, Brukewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 1998;338:557-63.
9. Jardin A, Bensadoun H, Delauche-Cavallier MC, Attali P. Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF Group. Lancet 1991;337:1457-61.
10. Miller MI, Puchner PJ. Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up. Urology 1998;51:237-40.
11. Wilson JR, Urwin GH, Stower MJ. The changing practice of transurethral prostatectomy: a comparison of cases performed in 1990 and 2000. Ann R Coll Surg Engl 2004;86:428-31.
12. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999;162:1307-10.
13. Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Nandy I, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol 2010;57:123-31.
14. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2387-98.
15. Sieber PR, Rommel FM, Huffnagle HW, Breslin JA, Agusta VE, Harpster LE. The treatment of gross hematuria secondary to prostatic bleeding with finasteride. J Urol 1998;159:1232-3.
16. Shin YS, Park JK. Changes in surgical strategy for patients with benign prostatic hyperplasia: 12-year single-center experience. Korean J Urol 2011;52:189-93.
17. Horninger W, Unterlechner H, Strasser H, Bartsch G. Transurethral prostatectomy: mortality and morbidity. Prostate 1996;28: 195-200.
18. Estey EP, Mador DR, McPhee MS. A review of 1486 transurethral resections of the prostate in a teaching hospital. Can J Surg 1993; 36:37-40.